Bone lessons from Marfan syndrome and related disorders: fibrillin, TGF-B and BMP at the balance of too long and too short.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Loeys BL;Loeys BL; Mortier G; Dietz HC
  • Source:
    Pediatric endocrinology reviews : PER [Pediatr Endocrinol Rev] 2013 Jun; Vol. 10 Suppl 2, pp. 417-23.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Y.S. Medical Media Ltd Country of Publication: Israel NLM ID: 101202124 Publication Model: Print Cited Medium: Print ISSN: 1565-4753 (Print) Linking ISSN: 15654753 NLM ISO Abbreviation: Pediatr Endocrinol Rev Subsets: MEDLINE
    • Publication Information:
      Original Publication: Netanya, Israel : Y.S. Medical Media Ltd.
    • Subject Terms:
    • Abstract:
      The extracellular matrix (ECM) is a complex entity with structural proteins (such as fibrillins, collagen, elastin), ground substance (proteoglycans), modifying enzymes (ADAMTS, PLOD, lysyloxidases (LOX)) and cytokines that regulate morphogenesis, growth, homeostasis and repair (transforming growth factor-beta [TGF-beta], bone morphogenic protein [BMP]). Over the last decade, the intimate relationship between structural proteins and these growth factors has emerged. The study of the extracellular matrix in human conditions and relevant mouse models is gradually unmasking the key role of these structural molecules in the regulation of the bio-availability of these growth factors. Major progress has been made in the study of the cardiovascular system (1) and the first clues in the skeletal system have emerged. (2) In this review, we will discuss the clinical, molecular, and pathogenic aspects of Marfan syndrome, Loeys-Dietz syndrome and related disorders with emphasis on the role of fibrillins and TGF-beta.
    • Accession Number:
      0 (Bone Morphogenetic Proteins)
      0 (Fibrillins)
      0 (Microfilament Proteins)
      0 (Transforming Growth Factor beta)
    • Publication Date:
      Date Created: 20130718 Date Completed: 20130813 Latest Revision: 20161125
    • Publication Date:
      20221213
    • Accession Number:
      23858625